Immunogenicity of influenza vaccine in elderly people: a systematic review and meta-analysis of randomized controlled trials, and its association with real-world effectiveness

Background: Older people (≥60 years old) are particularly vulnerable to influenza virus infection, and vaccine is effective in reducing the disease burden in this population. However, it remains obscure whether their antibody response is lower than those of younger adults (18–60 years old). Thus, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Ziyan, Zhang, Jiayou, Shi, Jinrong, Zhao, Wei, Huang, Xiaoyuan, Cheng, Li, Yang, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746244/
https://www.ncbi.nlm.nih.gov/pubmed/32347787
http://dx.doi.org/10.1080/21645515.2020.1747375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746244/
https://www.ncbi.nlm.nih.gov/pubmed/32347787
http://dx.doi.org/10.1080/21645515.2020.1747375

Ejemplares similares